Title:
Ｃ型肝炎ウイルス阻害剤
Document Type and Number:
Japanese Patent JP5619289
Kind Code:
B2
Abstract:
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
More Like This:
| JP2018505897 | Pyrazole compound |
| WO/2016/178250 | PROCESS FOR THE PREPARATION OF DACLATASVIR |
| JP7202315 | BCL6 inhibitor derived from benzimidazolone |
Inventors:
マコネン・ベレマ
ピヤセナ・ヘワワサム
ピヤセナ・ヘワワサム
Application Number:
JP2013530121A
Publication Date:
November 05, 2014
Filing Date:
September 24, 2010
Export Citation:
Assignee:
ブリストル−マイヤーズ スクイブ カンパニーＢＲＩＳＴＯＬ−ＭＹＥＲＳ ＳＱＵＩＢＢ ＣＯＭＰＡＮＹ
International Classes:
C07D403/14; A61K31/4178; A61P1/16; A61P31/14; C07D405/14
Attorney, Agent or Firm:
Yasuo Tamura
Mutsumi Sameshima
Hisatoshi Shinagawa
Yasushi Morimoto
Mutsumi Sameshima
Hisatoshi Shinagawa
Yasushi Morimoto